These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32645375)

  • 1. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in Ethiopia: A systematic review and meta-analysis.
    Alemu A; Bitew ZW; Worku T
    Int J Infect Dis; 2020 Sep; 98():420-439. PubMed ID: 32645375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study.
    Ketema DB; Muchie KF; Andargie AA
    BMC Public Health; 2019 Nov; 19(1):1481. PubMed ID: 31703667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.
    Alene KA; Viney K; McBryde ES; Tsegaye AT; Clements AC
    Trop Med Int Health; 2017 Mar; 22(3):351-362. PubMed ID: 27978594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
    PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Seid G; Moga S; Abdella S; Gashu E; Eshetu K; Tollera G; Dangisso MH; Gumi B
    PLoS One; 2023; 18(7):e0286194. PubMed ID: 37467275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study.
    Merid MW; Gezie LD; Kassa GM; Muluneh AG; Akalu TY; Yenit MK
    BMC Infect Dis; 2019 Mar; 19(1):286. PubMed ID: 30917788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    Andargie A; Molla A; Tadese F; Zewdie S
    PLoS One; 2021; 16(3):e0248687. PubMed ID: 33735231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with drug-resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Gumi B
    Transbound Emerg Dis; 2022 Sep; 69(5):2559-2572. PubMed ID: 34741434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    Alemu A; Bitew ZW; Worku T; Gamtesa DF; Alebel A
    PLoS One; 2021; 16(6):e0253848. PubMed ID: 34181701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis.
    Alemu A; Bitew ZW; Diriba G; Gashu E; Seid G; Eshetu K; Kebede A; Gumi B
    BMJ Open; 2023 Apr; 13(4):e070143. PubMed ID: 37019479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study.
    Molie T; Teklemariam Z; Klinkenberg E; Dessie Y; Kumsa A; Mohammed H; Debebe A; Assefa D; Habte A; Bedru A; Fiseha D; Seyoum B
    BMC Infect Dis; 2019 Sep; 19(1):818. PubMed ID: 31533644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
    Diriba G; Tola HH; Alemu A; Yenew B; Gamtesa DF; Kebede A
    PLoS One; 2021; 16(10):e0258295. PubMed ID: 34624050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Weldegebreal S; Mebrahtu T
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):18-22. PubMed ID: 28157460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients' data analysis for outcome and effectiveness of the current regimens.
    Eshetie S; Alebel A; Wagnew F; Geremew D; Fasil A; Sack U
    BMC Infect Dis; 2018 Sep; 18(1):486. PubMed ID: 30261852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological distress and its effect on tuberculosis treatment outcomes in Ethiopia.
    Tola HH; Shojaeizadeh D; Garmaroudi G; Tol A; Yekaninejad MS; Ejeta LT; Kebede A; Karimi M; Kassa D
    Glob Health Action; 2015; 8():29019. PubMed ID: 26610316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    Tola HH; Holakouie-Naieni K; Mansournia MA; Yaseri M; Tesfaye E; Mahamed Z; Molla Sisay M
    PLoS One; 2020; 15(2):e0229284. PubMed ID: 32101580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.